Results 241 to 250 of about 207,744 (307)
A prospective real-world study of the efficacy and safety of aducanumab in China: Focus on early-onset and autosomal dominant Alzheimer's disease. [PDF]
Xiao J +10 more
europepmc +1 more source
No Evidence for an Association Between DIP2B Repeat Expansion and Neurological Disease
Movement Disorders, EarlyView.
Chia‐Ying Ko +9 more
wiley +1 more source

